Enatinib Capsule 4 mg contains Lenvatinib Mesylate, an oral targeted anticancer medication used in the treatment of several types of advanced cancers. It belongs to a class of drugs known as multikinase inhibitors, which work by blocking specific proteins involved in tumor growth and blood vessel formation. By interfering with these pathways, Enatinib helps slow down or stop the growth and spread of cancer cells in the body.

Lenvatinib is primarily used in the treatment of differentiated thyroid cancer (DTC) that no longer responds to radioactive iodine therapy. It is also prescribed for hepatocellular carcinoma (liver cancer), renal cell carcinoma (kidney cancer) in combination with other therapies, and advanced endometrial cancer in certain patients. This medication is especially beneficial for patients with progressive or metastatic disease where other treatments may not be effective.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Enatinib Capsule 4 mg works by inhibiting several important receptor tyrosine kinases involved in tumor angiogenesis and cancer cell proliferation. These include vascular endothelial growth factor (VEGF) receptors, fibroblast growth factor (FGF) receptors, platelet-derived growth factor (PDGF) receptor, RET, and KIT signaling pathways. By blocking these pathways, the drug reduces the tumor’s blood supply and limits cancer growth.

The capsule is taken orally, usually once daily, with or without food. The dosage and duration of therapy depend on the type of cancer being treated, the patient's overall health condition, and response to therapy. Doctors may adjust the dose based on tolerance or the occurrence of side effects. Patients should follow the prescribed treatment plan carefully and should not stop taking the medication without medical advice.

Because Enatinib affects tumor blood vessel formation, it can significantly slow disease progression and improve outcomes in patients with certain cancers. However, as with many targeted cancer therapies, careful monitoring is required during treatment to ensure safety and effectiveness.

Composition

• Lenvatinib Mesylate 4 mg

Indications

Enatinib Capsule 4 mg is indicated for the treatment of:

• Radioactive iodine-refractory differentiated thyroid cancer

• Hepatocellular carcinoma (liver cancer)

• Renal cell carcinoma (kidney cancer), often in combination with other medications

• Advanced endometrial cancer in combination with immunotherapy

Mechanism of Action

Lenvatinib acts as a multikinase inhibitor that targets several receptor tyrosine kinases responsible for tumor cell proliferation and angiogenesis. It blocks receptors such as VEGFR, FGFR, PDGFR-alpha, RET, and KIT. By inhibiting these signaling pathways, the drug reduces blood vessel formation within tumors and slows down cancer cell growth and spread.

Dosage and Administration

• The dosage is determined by a physician depending on the cancer type and patient condition.

• Capsules should be taken once daily at the same time each day.

• Swallow the capsule whole with water; do not crush or chew it.

• It may be taken with or without food.

• Dose adjustments may be required in case of adverse reactions.

Possible Side Effects

Common side effects may include:

• High blood pressure

• Fatigue or weakness

• Diarrhea

• Loss of appetite

• Weight loss

• Nausea or vomiting

• Joint or muscle pain

• Mouth sores

Serious side effects may include severe hypertension, liver problems, bleeding, kidney impairment, or heart complications. Patients should report any unusual symptoms to their healthcare provider immediately.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Precautions and Warnings

• Blood pressure should be monitored regularly during treatment.

• Use with caution in patients with heart disease, liver disease, or kidney problems.

• Not recommended during pregnancy or breastfeeding due to potential harm to the baby.

• Effective contraception should be used during treatment and for some time after therapy.

• Regular medical monitoring, including laboratory tests, is recommended during treatment.

Storage

• Store below 30°C in a cool and dry place.

• Protect from moisture and direct sunlight.

• Keep out of reach of children.